Pharma & Biotech

A fascinating divergence is unfolding among major investors regarding pharmaceutical heavyweight Eli Lilly. The company finds itself at the center...

Ocugen has captured market attention with a bold regulatory roadmap, announcing plans to submit three gene therapy applications to the...

The biotechnology sector is witnessing one of its most compelling growth narratives with Madrigal Pharmaceuticals, whose shares have delivered extraordinary...

Investors in Cytokinetics are experiencing heightened tension as the biotechnology firm navigates a complex approval pathway for its cardiac treatment...

The genomics sector is witnessing a tale of two narratives unfold at Illumina, where groundbreaking artificial intelligence initiatives are being...

Theriva Biologics has initiated a severe corporate restructuring program, eliminating 32% of its global workforce—a reduction of seven positions—in a...

Friday's trading session witnessed significant volatility in Sonoma Pharmaceuticals stock, with the share price swinging more than 11% before ultimately...

Aptevo Therapeutics continues to experience one of the most dramatic stock market declines this year, with shares plummeting nearly 99%...

The recently finalized merger between Pieris Pharmaceuticals and Palvella Therapeutics has generated significant optimism among market analysts, with several firms...

Despite showing short-term upward momentum, shares of In8bio Inc are displaying concerning technical patterns that warrant investor attention. The stock...